Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

Collaboration Between Sheba and the UAE Health Authorities Reaches New Heights

UAE Health
Prof. Dudkiewicz, Chairman of Sheba’s Rehabilitation Division, visited hospitals in the UAE to share his expertise

After signing the Abraham Accords in 2020, which normalized relations between Israel and the UAE, Sheba Medical Center signed a memorandum of understanding with health authorities in Abu Dhabi. Consequently, Sheba will provide healthcare services via its virtual hospital – Sheba Beyond.

Prof. Israel Dudkiewicz, Chairman of the Rehabilitation Division at Sheba Medical Center, recently visited the United Arab Emirates (UAE) as part of the Visiting Professors Project.
This first visit, which lasted for several days, paves the way for future collaborations between Sheba and the Emirates Health Ministry.

UAE Health - Prof. Dudkiewicz at Physiotherapy and Sports Centre

One of the visit’s goals was to share know-how with local medical teams. An expert orthopedic surgeon, Prof. Dudkiewicz visited two hospitals, one of which is a rehabilitation hospital, and consulted on several medical cases requiring complex rehabilitation.


Ayelet’s Miracle: The First Woman to Conceive Four Children Following Ovarian Tissue Cryopreservation

At 21, Ayelet Rozenberg was diagnosed with Hodgkin’s lymphoma. Facing aggressive therapies necessary to save her life, Ayelet feared she would never be able to…
Read More
bowel disease
News Sep 07.

Sheba Partners with Biomica to Advance Inflammatory Bowel Disease Care

As part of the new collaboration, Sheba and Biomica will engage in joint microbiome clinical research to develop better treatments for inflammatory bowel disease (IBD)…
Read More
Hemophilia research
News Sep 05.

New Sheba Study Indicates: Novel Treatment Sharply Reduces Bleed Rates Among Hemophilia Patients

Results indicate that a monthly treatment with Fitusiran significantly reduces bleed rates among both hemophilia A and B patients.
Read More